181 related articles for article (PubMed ID: 32024621)
1. Alpha-glucosidase inhibition and molecular docking studies of 1,2-benzothiazine 1,1-dioxide based carbohydrazides.
Saddique FA; Ahmad M; Ashfaq UA; Ahmad MN; Anjum MN; Mohsin NA; Aslam S
Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2829-2834. PubMed ID: 32024621
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2
Saddique FA; Aslam S; Ahmad M; Ashfaq UA; Muddassar M; Sultan S; Taj S; Hussain M; Sung Lee D; Zaki MEA
Molecules; 2021 May; 26(10):. PubMed ID: 34065194
[TBL] [Abstract][Full Text] [Related]
3. In-silico modeling and in-vitro studies of 2,1-benzothiazine-2,2-dioxide based hydrazone derivatives as α-glucosidase inhibitors.
Ahmad S; Taj S; Aslam S; Gul Khan S; Farooq T; Ashfaq UA; Ahmad M
Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1951-1955. PubMed ID: 34836865
[TBL] [Abstract][Full Text] [Related]
4. Exploring of novel 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study.
Taj S; Ahmad M; Ashfaq UA
Int J Biol Macromol; 2022 May; 207():507-521. PubMed ID: 35276296
[TBL] [Abstract][Full Text] [Related]
5. Anti-Diabetic Activity of 2,3,6-Tribromo-4,5-Dihydroxybenzyl Derivatives from
Paudel P; Seong SH; Park HJ; Jung HA; Choi JS
Mar Drugs; 2019 Mar; 17(3):. PubMed ID: 30875760
[TBL] [Abstract][Full Text] [Related]
6. Morning glory resin glycosides as α-glucosidase inhibitors: In vitro and in silico analysis.
Rosas-Ramírez D; Escandón-Rivera S; Pereda-Miranda R
Phytochemistry; 2018 Apr; 148():39-47. PubMed ID: 29421509
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
[TBL] [Abstract][Full Text] [Related]
8. Molecular Docking of Isolated Alkaloids for Possible α-Glucosidase Inhibition.
Rahman N; Muhammad I; ; Khan H; Aschner M; Filosa R; Daglia M
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569830
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
10. 2-Mercapto Benzothiazole Derivatives: As Potential Leads for the Diabetic Management.
Ullah S; Mirza S; Salar U; Hussain S; Javaid K; Khan KM; Khalil R; Atia-Tul-Wahab ; Ul-Haq Z; Perveen S; Choudhary MI
Med Chem; 2020; 16(6):826-840. PubMed ID: 31195949
[TBL] [Abstract][Full Text] [Related]
11. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI
Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232
[TBL] [Abstract][Full Text] [Related]
12. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
13. Giganteone A and malabaricone C as potential pharmacotherapy for diabetes mellitus.
Sivasothy Y; Leong KH; Loo KY; Adbul Wahab SM; Othman MA; Awang K
Nat Prod Res; 2022 Mar; 36(6):1581-1586. PubMed ID: 33593208
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic investigation of anthocyanidin derivatives as α-glucosidase inhibitors.
Kim JH; Kim HY; Jin CH
Bioorg Chem; 2019 Jun; 87():803-809. PubMed ID: 30978605
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
20. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J
Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
